$225 Million is the total value of Kingfisher Capital LLC's 138 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKA | Berkshire Hathaway Inc - A sharesequities | $802,000 | -1.7% | 3 | 0.0% | 0.36% | -15.0% | |
VIG | Vanguard Dividend Appreciation ETFequities | $539,000 | +13.5% | 4,596 | 0.0% | 0.24% | -2.0% | |
GOOG | Alphabet Inc Class Cequities | $465,000 | +21.4% | 329 | 0.0% | 0.21% | +5.1% | |
LLY | Eli Lilly and Companyequities | $460,000 | +18.6% | 2,800 | 0.0% | 0.20% | +2.5% | |
AMAT | Applied Materials, Inc.equities | $315,000 | +31.8% | 5,206 | 0.0% | 0.14% | +13.8% | |
Alcanna Incequities | $26,000 | +62.5% | 10,000 | 0.0% | 0.01% | +50.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corporation | 45 | Q2 2024 | 2.7% |
Johnson & Johnson | 45 | Q2 2024 | 1.7% |
Pfizer Inc. | 45 | Q2 2024 | 1.2% |
Coca-Cola Company | 45 | Q2 2024 | 1.0% |
Exxon Mobil Corporation | 45 | Q2 2024 | 1.5% |
Procter & Gamble Company | 45 | Q2 2024 | 1.2% |
Union Pacific Corporation | 45 | Q2 2024 | 1.1% |
AbbVie, Inc. | 45 | Q2 2024 | 0.8% |
PepsiCo | 45 | Q2 2024 | 0.5% |
Colgate-Palmolive Company | 45 | Q2 2024 | 1.3% |
View Kingfisher Capital LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-30 |
13F-HR | 2024-08-14 |
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-02 |
13F-HR | 2023-01-19 |
13F-HR | 2022-11-01 |
13F-HR | 2022-07-29 |
View Kingfisher Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.